These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36406478)

  • 21. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
    J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.
    Fihel A; Janicka A; Buschner A; Ustinavičienė R; Trakienė A
    PLoS One; 2024; 19(7):e0307194. PubMed ID: 39012883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
    Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
    JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
    Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and Cardiovascular Comorbidities.
    Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O
    Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    McKeigue PM; Weir A; Bishop J; McGurnaghan SJ; Kennedy S; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Ramsay C; Hutchinson S; Colhoun HM;
    PLoS Med; 2020 Oct; 17(10):e1003374. PubMed ID: 33079969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
    PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.
    Bonnet G; Weizman O; Trimaille A; Pommier T; Cellier J; Geneste L; Panagides V; Marsou W; Deney A; Attou S; Delmotte T; Ribeyrolles S; Chemaly P; Karsenty C; Giordano G; Gautier A; Chaumont C; Guilleminot P; Sagnard A; Pastiero J; Ezzouhairi N; Perin B; Zakine C; Levasseur T; Ma I; Chavignier D; Noirclerc N; Darmon A; Mevelec M; Duceau B; Sutter W; Mika D; Fauvel C; Pezel T; Waldmann V; Cohen A;
    Arch Cardiovasc Dis; 2021 May; 114(5):352-363. PubMed ID: 34154953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.
    Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J
    Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 in the Indigenous Population of Brazil.
    Palamim CVC; Ortega MM; Marson FAL
    J Racial Ethn Health Disparities; 2020 Dec; 7(6):1053-1058. PubMed ID: 33025421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
    Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
    Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19's immuno-pathology and cardiovascular diseases.
    Nasab EM; Aghajani H; Makoei RH; Athari SS
    J Investig Med; 2023 Feb; 71(2):71-80. PubMed ID: 36647329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
    Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
    Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.
    Atkins JL; Masoli JAH; Delgado J; Pilling LC; Kuo CL; Kuchel GA; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2224-2230. PubMed ID: 32687551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.